How peptide synthesis works

Build a chain. Keep it attached.

Solid-phase peptide synthesis, or SPPS, is a widely used approach to producing synthetic peptides. The growing chain remains attached to an insoluble support while amino-acid residues are added in sequence. After each reaction, soluble reagents and by-products can be washed away while the attached material stays in place.

This was a major change from approaches that required isolation of the growing product after each stage. Robert Bruce Merrifield’s development of synthesis on a solid matrix was recognised by the 1984 Nobel Prize in Chemistry. Modern workflows use this principle in many forms, including automated systems.

SPPS is one manufacturing approach, not a guarantee of final quality. Sequence difficulty, reaction control, purification, and analytical characterisation all affect the material ultimately recovered. Understanding the process explains why a finished peptide needs more than a claim that the intended sequence was synthesised.

Control which groups react.

Amino acids contain more than one reactive group, and many side chains introduce additional possibilities. Protecting groups temporarily block selected sites so that the intended peptide bond can form at the intended position. Without that control, the chemistry would produce a much more complicated mixture.

In a common Fmoc-based approach, temporary protection of the growing amino terminus is removed under conditions that leave other protections in place. The next protected amino acid can then be coupled. This selective behaviour is often described as orthogonality: one protecting strategy can be changed while another remains effective.

The growing chain is conventionally extended from its C-terminal end toward its N-terminal end in standard SPPS. This direction differs from the usual way a sequence is written on a page. The manufacturing order and the sequence notation describe the same target from different perspectives.

A repeated cycle creates the sequence.

At a conceptual level, the process alternates between exposing the next reactive site, washing, adding a protected residue, and washing again. Those operations repeat as the chain grows. At the end, cleavage releases the peptide from the support and removes remaining protections under the chosen chemistry.

The recovered material is a crude mixture. Even efficient reactions can leave a fraction of chains incomplete or modified. Small inefficiencies accumulate over many steps, and difficult sequences may present additional problems such as aggregation on the support or reduced accessibility of reactive sites.

This overview describes the logic of the process, rather than a manufacturing protocol. Reagent selection, conditions, and controls are specific to the sequence, chemistry, and equipment.

Why near-neighbours can remain.

Some related species are close to the intended peptide in mass or chromatographic behaviour. Their similarity can make separation and identification challenging. A nominal sequence description alone does not reveal which of these species are present in a particular material.

Purification and measurement work together.

Preparative chromatography separates material at a scale suitable for collection. Fractions can be evaluated, selected, and combined according to defined criteria. The collected material may then undergo further processing, counterion exchange where appropriate, and lyophilisation.

Preparative and analytical chromatography share separation principles but serve different purposes. One is used to obtain material; the other characterises a sample under a defined method. A successful purification step must still be followed by measurements that describe what was recovered.

HPLC can assess chromatographic purity, while mass spectrometry supports investigation of expected mass and identity. Other methods may address water, counterions, content, or particular impurities. Peptide reference-standard research illustrates why these properties are considered together.

The practical lesson for reading a catalog is straightforward: synthesis names the production approach, purification changes the composition, and analysis provides evidence about the resulting sample. None of those steps should be silently substituted for the others.

References & further reading

The sources below provide scientific context for the concepts in this guide. They do not constitute GLPZone product certifications or batch reports.

1. The Nobel Prize in Chemistry 1984 · Robert Bruce Merrifield
2. Sharma et al., 2022 · Synthetic Pharmaceutical Peptides Characterization by Chromatography
3. McCarthy et al., 2023 · Reference Standards to Support Quality of Synthetic Peptide Therapeutics
4. Hoofnagle et al., 2016 · Generation, Quantification, Storage and Handling of Peptides Used for Mass Spectrometry-Based Assays